Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Acq. announced
CC transcript
Employment agrmnt
Coll. bargaining agrmnt
Director departure
NOVELION THERAPEUTICS INC. (NVLNF) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/15/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
12/12/2019 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Bought 5,202 shares @ $0.6916, valued at $3.6k
Bought 40 shares @ $0.69, valued at $27.6
Bought 1,000 shares @ $0.7, valued at $700
12/09/2019 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Bought 5,160 shares @ $0.7, valued at $3.6k
Bought 40 shares @ $0.7, valued at $28
Bought 4,500 shares @ $0.7, valued at $3.2k
11/26/2019 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Bought 89,845 shares @ $0.7461, valued at $67k
10/16/2019 4 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Bought 100,000 shares @ $0.649, valued at $64.9k
10/02/2019 3 STONEPINE CAPITAL, L.P. (10% Owner) has filed a Form 3 on NOVELION THERAPEUTICS INC.
09/26/2019 4 PRICE MICHAEL DENNIS (CFO) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 3,926 shares @ $0.76, valued at $3k
09/26/2019 4 Chan Barbara Y (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 1,688 shares @ $0.76, valued at $1.3k
05/13/2019 4 Louis Roger (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 155 shares @ $1.22, valued at $189.1
05/13/2019 4 Buono Linda (Sr. VP, Human Resources) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 77 shares @ $1.22, valued at $93.9
05/13/2019 4 Harshbarger Benjamin (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 212 shares @ $1.22, valued at $258.6
03/19/2019 4 Chan Barbara Y (See remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 996 shares @ $1.26, valued at $1.3k
12/27/2018 4 Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Sold 400 shares @ $0.98, valued at $392
Sold 1,200 shares @ $0.9325, valued at $1.1k
Sold 83,245 shares @ $0.9784, valued at $81.4k
Sold 12,450 shares @ $0.9078, valued at $11.3k
Sold 109,900 shares @ $0.872, valued at $95.8k
Sold 12,219 shares @ $0.9091, valued at $11.1k
Sold 28,745 shares @ $0.9058, valued at $26k
Sold 30,726 shares @ $0.907, valued at $27.9k
Sold 14,800 shares @ $0.8803, valued at $13k
Sold 56,316 shares @ $0.8548, valued at $48.1k
Sold 100,000 shares @ $0.8514, valued at $85.1k
12/10/2018 4 Chan Barbara Y (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 3,313 shares @ $1.28, valued at $4.2k
11/28/2018 4 PRICE MICHAEL DENNIS (CFO) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 1,963 shares @ $0.92, valued at $1.8k
11/05/2018 4 Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 322 shares @ $4.26, valued at $1.4k
Paid exercise price by delivering 150 shares @ $4.15, valued at $622.5
Paid exercise price by delivering 98 shares @ $3.94, valued at $386.1
11/05/2018 4 HACKMAN JEFFREY (C.O.O. and Interim C.E.O.) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 32,149 shares @ $0.8971, valued at $28.8k
08/27/2018 4 Chan Barbara Y (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 50,000 options to buy @ $0
08/13/2018 4 Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Gifted 10,000 options to buy @ $0
08/13/2018 4 DiPaolo Mark (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 10,000 options to buy @ $0
08/13/2018 4 ORLOFF JOHN J (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 10,000 options to buy @ $0
08/13/2018 4 Sabba Stephen L (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 10,000 options to buy @ $0
08/13/2018 4 Bruhn Suzanne Louise (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 10,000 options to buy @ $0
08/13/2018 4 Stern Donald K (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 10,000 options to buy @ $0
08/13/2018 4 Thomas John C (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 10,000 options to buy @ $0
08/13/2018 4 CORRIGAN MARK (Director) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 50,000 options to buy @ $0
05/11/2018 4 Louis Roger (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 161 shares @ $4.26, valued at $685.9
05/11/2018 4 Buono Linda (Sr. VP, Human Resources) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 80 shares @ $4.26, valued at $340.8
04/03/2018 4 Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Paid exercise price by delivering 52 shares @ $3.5, valued at $182
03/26/2018 4 Chan Barbara Y (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 8,600 shares @ $0
Granted 40,000 options to buy @ $0
03/19/2018 4 Broadfin Healthcare Master Fund Ltd (10% Owner) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 909,296 warrants @ $4.4, valued at $4M
02/14/2018 4 Stewart Murray (Executive Vice President, R&D) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 45,000 options to buy @ $0
02/14/2018 4 Harshbarger Benjamin (General Counsel) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 45,000 options to buy @ $0
02/14/2018 4 Louis Roger (See Remarks) has filed a Form 4 on NOVELION THERAPEUTICS INC.
Txns: Granted 25,000 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy